126 related articles for article (PubMed ID: 27931821)
41. In vivo genotoxicity assessment of N-(-9 acridinyl)-b-alanine hydrochloride (S-300) using a validated Pig-a mutagenesis assay.
North A; Ling K; Ricaud G; Stankowski LF; Daly JA; Bentow S; Corash L; Benjamin RJ; Mufti N
Transfusion; 2024 Jun; 64(6):1097-1108. PubMed ID: 38716879
[TBL] [Abstract][Full Text] [Related]
42. Assessment of genotoxicity induced by 7,12-dimethylbenz(a)anthracene or diethylnitrosamine in the Pig-a, micronucleus and Comet assays integrated into 28-day repeat dose studies.
Shi J; Krsmanovic L; Bruce S; Kelly T; Paranjpe M; Szabo K; Arevalo M; Atta-Safoh S; Debelie F; LaForce MK; Sly J; Springer S
Environ Mol Mutagen; 2011 Dec; 52(9):711-20. PubMed ID: 21976072
[TBL] [Abstract][Full Text] [Related]
43. Diethylnitrosamine genotoxicity evaluated in sprague dawley rats using pig-a mutation and reticulocyte micronucleus assays.
Avlasevich SL; Phonethepswath S; Labash C; Carlson K; Torous DK; Cottom J; Bemis JC; MacGregor JT; Dertinger SD
Environ Mol Mutagen; 2014 Jun; 55(5):400-6. PubMed ID: 24574022
[TBL] [Abstract][Full Text] [Related]
44. International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories.
Dertinger SD; Phonethepswath S; Weller P; Nicolette J; Murray J; Sonders P; Vohr HW; Shi J; Krsmanovic L; Gleason C; Custer L; Henwood A; Sweder K; Stankowski LF; Roberts DJ; Giddings A; Kenny J; Lynch AM; Defrain C; Nesslany F; van der Leede BJ; Van Doninck T; Schuermans A; Tanaka K; Hiwata Y; Tajima O; Wilde E; Elhajouji A; Gunther WC; Thiffeault CJ; Shutsky TJ; Fiedler RD; Kimoto T; Bhalli JA; Heflich RH; MacGregor JT
Environ Mol Mutagen; 2011 Dec; 52(9):690-8. PubMed ID: 21910140
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of in vivo genotoxicity induced by N-ethyl-N-nitrosourea, benzo[a]pyrene, and 4-nitroquinoline-1-oxide in the Pig-a and gpt assays.
Horibata K; Ukai A; Kimoto T; Suzuki T; Kamoshita N; Masumura K; Nohmi T; Honma M
Environ Mol Mutagen; 2013 Dec; 54(9):747-54. PubMed ID: 24105957
[TBL] [Abstract][Full Text] [Related]
46. Characterization of benzo[a]pyrene and colchicine based on an in vivo repeat-dosing multi-endpoint genotoxicity quantitative assessment platform.
Zeng Z; Huo J; Zhu X; Liu Y; Li R; Chen Y; Zhang L; Chen J
Mutagenesis; 2022 Oct; 37(3-4):213-225. PubMed ID: 35869703
[TBL] [Abstract][Full Text] [Related]
47. Pig-a gene mutation and micronucleated reticulocyte induction in rats exposed to tumorigenic doses of the leukemogenic agents chlorambucil, thiotepa, melphalan, and 1,3-propane sultone.
Dertinger SD; Phonethepswath S; Avlasevich SL; Torous DK; Mereness J; Cottom J; Bemis JC; Macgregor JT
Environ Mol Mutagen; 2014 May; 55(4):299-308. PubMed ID: 24449360
[TBL] [Abstract][Full Text] [Related]
48. Comparison of male versus female responses in the Pig-a mutation assay.
Labash C; Avlasevich SL; Carlson K; Torous DK; Berg A; Bemis JC; MacGregor JT; Dertinger SD
Mutagenesis; 2015 May; 30(3):349-57. PubMed ID: 25833915
[TBL] [Abstract][Full Text] [Related]
49. Caffeic Acid Genotoxicity: Correlation of the Pig-a Assay with Regulatory Genetic Toxicology In Vivo Endpoints.
Bhalli JA; Neft R; Noteboom J; Tebbe CC; Chan M; Kuhn K; Pearce G; Jordan L; Beevers C
Environ Mol Mutagen; 2019 Dec; 60(9):837-844. PubMed ID: 31490579
[TBL] [Abstract][Full Text] [Related]
50. Standard protocol for the total red blood cell
Chikura S; Kimoto T; Itoh S; Sanada H; Muto S; Horibata K
Genes Environ; 2019; 41():5. PubMed ID: 30858897
[TBL] [Abstract][Full Text] [Related]
51. Applying the erythrocyte Pig-a assay concept to rat epididymal sperm for germ cell mutagenicity evaluation.
Ji Z; LeBaron MJ
Environ Mol Mutagen; 2017 Aug; 58(7):485-493. PubMed ID: 28714084
[TBL] [Abstract][Full Text] [Related]
52. Manifestation and persistence of Pig-a mutant red blood cells in C57BL/6 mice following single and split doses of N-ethyl-N-nitrosourea.
Bhalli JA; Pearce MG; Dobrovolsky VN; Heflich RH
Environ Mol Mutagen; 2011 Dec; 52(9):766-773. PubMed ID: 22167887
[TBL] [Abstract][Full Text] [Related]
53. Integration of Pig-a, micronucleus, chromosome aberration and comet assay endpoints in a 28-day rodent toxicity study with urethane.
Stankowski LF; Aardema MJ; Lawlor TE; Pant K; Roy S; Xu Y; Elbekai R
Mutagenesis; 2015 May; 30(3):335-42. PubMed ID: 25934985
[TBL] [Abstract][Full Text] [Related]
54. In vivo pig-a and micronucleus study of the prototypical aneugen vinblastine sulfate.
Avlasevich SL; Labash C; Torous DK; Bemis JC; MacGregor JT; Dertinger SD
Environ Mol Mutagen; 2018 Jan; 59(1):30-37. PubMed ID: 28833575
[TBL] [Abstract][Full Text] [Related]
55. International Pig-a gene mutation assay trial (stage III): results with N-methyl-N-nitrosourea.
Lynch AM; Giddings A; Custer L; Gleason C; Henwood A; Aylott M; Kenny J
Environ Mol Mutagen; 2011 Dec; 52(9):699-710. PubMed ID: 22167885
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the Pig-a, micronucleus, and comet assay endpoints in a 28-day study with ethyl methanesulfonate.
Gunther WC; Coffing SL; Dickinson DA; Engel ME; Fiedler RD; O'Lone SD; Sanok KE; Thiffeault CJ; Shutsky TJ; Schuler MJ; Dobo KL
Environ Mol Mutagen; 2014 Jul; 55(6):492-9. PubMed ID: 24599777
[TBL] [Abstract][Full Text] [Related]
57. Monitoring genotoxicity in patients receiving chemotherapy for cancer: application of the PIG-A assay.
Horibata K; Ukai A; Ishikawa S; Sugano A; Honma M
Mutat Res Genet Toxicol Environ Mutagen; 2016 Sep; 808():20-6. PubMed ID: 27637482
[TBL] [Abstract][Full Text] [Related]
58. Application of the in vivo Pig-a gene mutation assay to test the potential genotoxicity of p-phenylenediamine.
Qin M; Chen R; Huang Z; Wang J; Xu S; Jiang R; Li J; Xian J; Wang X; Lu Y; Xu L; Chen N; Chen X; Wang P; Wang T
Food Chem Toxicol; 2019 Jan; 123():424-430. PubMed ID: 30439388
[TBL] [Abstract][Full Text] [Related]
59. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea.
Miura D; Dobrovolsky VN; Kimoto T; Kasahara Y; Heflich RH
Mutat Res; 2009; 677(1-2):86-92. PubMed ID: 19501187
[TBL] [Abstract][Full Text] [Related]
60. Pig-a gene mutation assay study design: critical assessment of 3- versus 28-day repeat-dose treatment schedules.
Elhajouji A; Hove TT; O'Connell O; Martus H; Dertinger SD
Mutagenesis; 2020 Sep; 35(4):349-358. PubMed ID: 32608486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
